Diabetes drugs prescribed to more than 15 million Americans raises risk of bladder cancer, Penn Medicine study shows

PHILADELPHIA, PA USA (Press Release) - August 13, 2012 - A popular class of diabetes drugs increases patients’ risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute. To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.

Tags:
Comments (0)
Only registered users can write comments!